-
公开(公告)号:US12104179B2
公开(公告)日:2024-10-01
申请号:US18474786
申请日:2023-09-26
Applicant: EMPYREAN NEUROSCIENCE, INC.
Inventor: Thomas Henley , Modassir Choudhry , Jose Fernandez-Gomez , Antoine Larrieu , Beata Orman-Ligeza , Umar Mohammed , Emma McKechnie-Welsh
CPC classification number: C12N9/1007 , A61K35/66 , C12N9/22 , C12N15/11 , C12N2310/20 , C12N2800/80
Abstract: This disclosure provides genetically engineered organisms with genetic modifications that are useful for producing desirable alkaloids. This disclosure also provides methods of making genetically engineered organisms that can produce desirable alkaloids. The organisms described herein produce alkaloids in amounts beyond that produced from comparable wild-type organisms. In certain embodiments, the genetically engineered organisms are fungi from the Basidiomycota division.
-
公开(公告)号:US20240101976A1
公开(公告)日:2024-03-28
申请号:US18474786
申请日:2023-09-26
Applicant: EMPYREAN NEUROSCIENCE, INC.
Inventor: Thomas HENLEY , Modassir CHOUDHRY , Jose FERNANDEZ-GOMEZ , Antoine LARRIEU , Beata ORMAN-LIGEZA , Umar MOHAMMED , Emma MCKECHNIE-WELSH
CPC classification number: C12N9/1007 , A61K35/66 , C12N9/22 , C12N15/11 , C12N2310/20 , C12N2800/80
Abstract: This disclosure provides genetically engineered organisms with genetic modifications that are useful for producing desirable alkaloids. This disclosure also provides methods of making genetically engineered organisms that can produce desirable alkaloids. The organisms described herein produce alkaloids in amounts beyond that produced from comparable wild-type organisms. In certain embodiments, the genetically engineered organisms are fungi from the Basidiomycota division.
-
公开(公告)号:US20220396780A1
公开(公告)日:2022-12-15
申请号:US17812826
申请日:2022-07-15
Applicant: EMPYREAN NEUROSCIENCE, INC.
Inventor: Thomas HENLEY , Modassir CHOUDHRY , Jose FERNANDEZ-GOMEZ
Abstract: Provided herein are methods for modulating the psilocybin biosynthesis pathway in fungi or other organisms. Also provided are genetically modified fungi and organisms with induced and/or increased expression of psilocybin and psilocin and psilocybin and/or psilocin compositions generated by the provided methods.
-
公开(公告)号:US20220306997A1
公开(公告)日:2022-09-29
申请号:US17711270
申请日:2022-04-01
Applicant: EMPYREAN NEUROSCIENCE, INC.
Inventor: Thomas HENLEY , Modassir CHOUDHRY , Jose FERNANDEZ-GOMEZ
Abstract: Provided herein are methods for modulating the psilocybin biosynthesis pathway in fungi or other organisms. Also provided are genetically modified fungi and organisms with induced and/or increased expression of psilocybin and psilocin and psilocybin and/or psilocin compositions generated by the provided methods.
-
公开(公告)号:US11905535B2
公开(公告)日:2024-02-20
申请号:US17812826
申请日:2022-07-15
Applicant: EMPYREAN NEUROSCIENCE, INC.
Inventor: Thomas Henley , Modassir Choudhry , Jose Fernandez-Gomez
CPC classification number: C12N9/0083 , A61K36/07 , C12N9/1007 , C12N9/1205 , C12N9/88 , C12Y114/99 , C12Y201/01 , C12Y207/01 , C12Y401/01
Abstract: Provided herein are methods for modulating the psilocybin biosynthesis pathway in fungi or other organisms. Also provided are genetically modified fungi and organisms with induced and/or increased expression of psilocybin and psilocin and psilocybin and/or psilocin compositions generated by the provided methods.
-
公开(公告)号:US20220307043A1
公开(公告)日:2022-09-29
申请号:US17711258
申请日:2022-04-01
Applicant: EMPYREAN NEUROSCIENCE, INC.
Inventor: Thomas HENLEY , Modassir CHOUDHRY , Jose FERNANDEZ-GOMEZ
IPC: C12N15/82 , A61K31/352
Abstract: Provided herein are methods for modulating the cannabinoid biosynthesis pathway in plants. Also provided are cannabinoid compositions comprising rare cannabinoids, new cannabinoids, and variant cannabinoids generated by the provided methods.
-
公开(公告)号:US20220298523A1
公开(公告)日:2022-09-22
申请号:US17711206
申请日:2022-04-01
Applicant: EMPYREAN NEUROSCIENCE, INC.
Inventor: Thomas HENLEY , Modassir CHOUDHRY , Jose FERNANDEZ-GOMEZ
IPC: C12N15/82 , C07K14/415 , C12N9/02 , C12N9/22
Abstract: Provided herein are compositions comprising genetically modified cells, organisms, or plants described herein or extracts and products thereof and methods for making and using the same. Also provided are therapeutics derived from genetically modified cells, organisms, or plants described herein or extracts and products thereof for use in preventing, treating, or stabilizing disease and conditions.
-
-
-
-
-
-